Cranial nerve palsies in childhood parameningeal rhabdomyosarcoma

Alexandra P Zorzi1, Ronald Grant, Abha A Gupta

  • 1Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Ontario, Canada. alexandra.zorzi@sickkids.ca

Insights

Children with parameningeal rhabdomyosarcoma and cranial nerve palsy often experience incomplete neurologic recovery. Further research is needed to determine the effectiveness of emergent therapies for this condition.

Area of Science:

  • Pediatric Oncology
  • Neurology
  • Radiation Oncology

Background:

  • Parameningeal rhabdomyosarcoma (PM RMS) in children can lead to permanent neurologic dysfunction due to cranial nerve palsy (CNP).
  • Limited data exists on the natural history of CNP in PM RMS, impacting treatment decisions for emergent therapies like radiation and corticosteroids.

Purpose of the Study:

  • To describe the clinical features of PM RMS patients with CNP.
  • To evaluate factors influencing neurologic recovery in these patients.

Main Methods:

  • Retrospective review of PM RMS cases treated at a single institution from 1985 to 2010.
  • Analysis of patient, disease, and treatment-related factors associated with CNP and neurologic outcomes.

Main Results:

  • 54% of PM RMS patients presented with CNP.
  • CNP was associated with higher risk features like cranial base bony erosion or intracranial extension.
  • Among survivors, neurologic recovery was incomplete in 55% despite multi-modal therapy, including expedited radiation and corticosteroids.

Conclusions:

  • Incomplete neurologic recovery is common for CNP associated with PM RMS, even with aggressive treatment.
  • Larger studies are necessary to establish the efficacy of emergent radiation or corticosteroid use.
  • Findings aid in counseling families about long-term neurologic outcomes for CNP in PM RMS.
Abstract

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...